# TEMODAR

NDC: 0085-1381
Generic name: Temozolomide
Labeler / Manufacturer: Merck Sharp & Dohme LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20090227

FDA application: NDA022277

## Active ingredients

- TEMOZOLOMIDE: 2.5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0085-1381"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0085-1381
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=046a9011-3911-4d3f-a15f-fbb56d5aad56